ArticleMicrobiology resource announcements2022
Draft Genome Sequence of Purpureocillium takamizusanense, a Potential Bioinsecticide.
Article in Microbiology resource announcements, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Nematicidal Potential ofMicroorganisms · 2026Article
- Article
- Comparative Mitogenomics Analysis Revealed Evolutionary Divergence amongMicroorganisms · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
To investigate the biocontrol capability of the entomopathogenic fungus Purpureocillium takamizusanense, the genome of the wild-type strain isolated from synnemata on Meimuna opalifera, was sequenced using a combination of HiSeq and Nanopore technologies, and annotated using evidence from RNA sequences and protein sequences from its sister species Purpureocillium lilacinum.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.